Visit
Apply
Give

Department of Pharmacy Practice

Sarah E. Petite, Pharm.D., BCPS

photo of Dr Petite
  Associate Professor
  Department of Pharmacy Practice
  Frederic and Mary Wolfe Center 114C
  Phone: 419.383.1964
  E-mail: sarah.petite@utoledo.edu

 

 

Area of Research

Inpatient diabetes and COPD management, transitions of care and pedagogy of clinical education.

Educational Background

Pharm.D. with a minor in Public Health Ohio Northern University, 2013

Training

  • PGY-1 and PGY-2 Pharmacotherapy Residency June 2013-June 2015, Cleveland Clinic
  • ASHP-Accredited Residency Program

Scope of Practice

  • Adjunct Faculty, University of Toledo College of Medicine, Toledo, Ohio, February 2018-present
  • Internal Medicine Clinical Pharmacy Specialist, ProMedica Toledo Hospital, Toledo, Ohio, July 2017-present
  • Internal Medicine Clinical Pharmacy Specialist, University of Toledo Medical Center, Toledo, Ohio, July 2015-June 2017
  • Medical Staff Membership and Clinical Privileges, February 2016-December 2017
  • Staff Pharmacist, Cleveland Clinic, Cleveland, Ohio, June 2013-June 2015

Awards, Honors and Grants

  1. Petite SE, Hill M. “Evaluation of dipeptidyl peptidase-IV inhibitor use in hospitalized patients with diabetes. ACCP Adult Medicine PRN Seed Grant Award. $4600. Scored; Funded at $2500. September 2019
  2. Petite SE, Murphy JA. “The impact of the implementation of a pharmacist driven COPD management program”. ASHP Foundation New Investigator Award. $20,000. Funded. February 2017
  3. Shout Out for Innovative Instructors and Staff Recognition, 2020
  4. APPE Outstanding Preceptor Nominee, 2017
  5. Faculty Inductee, Phi Lambda Sigma Pharmacy Leadership Society, 2016

Publications and journals

Peer Reviewed Publications

  1. Petite SE, Hill MC. Evaluation of dipeptidyl peptidase-IV inhibitor use in hospitalized patients with diabetes. Ann Pharmacother 2021. Epub ahead of print February 2021.
  2. Petite SE, Hill MC. Evaluation of dipeptidyl peptidase-IV inhibitor use in the inpatient setting. J Pharm Pract 2020. Epub ahead of print October 2020.
  3. Peeters MJ, Petite SE, Schroeder M, Cor MK. Validation evidence from using generalizability theory for an objective structured clinical examination. Innov Pharm 2020. Accepted, pending publication.
  4. Petite SE, Hess MW, Wachtel H. The role of the pharmacist in inhaler selection and education in chronic obstructive pulmonary disease. J Pharm Tech 2020. Epub ahead of print July 2020.
  5. Alauddin T, Petite SE. Evaluation of the safety and efficacy of metformin use in hospitalized, non-critically ill patients. J Pharm Tech 2020;36(3):102-109. Epub ahead of print March 2020.
  6. Petite SE, Murphy JA. Impact of a pharmacist-driven orderset on chronic obstructive pulmonary disease exacerbation orderset in the inpatient setting. Am J Health Syst Pharm 2020;77(14):1128-1134. Epub ahead of print July 2020.
  7. Kayyali A, Petite SE. Identification of deprescribing opportunities for patients with diabetes and dementia discharged to a nursing home using a mortality prognostic index. Drugs Ther Perspect 2020;36(1):41-46. Epub ahead of print November 2019.
  8. Petite SE. What is the role of triple inhaled therapy in COPD? JAAPA 2019;32(10):44-45.
  9. Cole K, Phlamon M, Petite SE. Comparison of short-course versus prolonged antimicrobial therapy in the management of intra-abdominal infections. Surg Infect 2019;20(6):519-523. Epub ahead of print May 2019.
  10. Petite SE, Huenecke J, Tuttle N. Evaluation of basal insulin dose reductions in hospitalized patients with diabetes while unable to eat. Hosp Pharm 2020;55(4):246-252. Epub ahead of print April 2019.
  11. Petite SE, Murphy JA. Systemic corticosteroid and antibiotic use in hospitalized patients with chronic obstructive pulmonary disease exacerbation. Ann Pharmacother 2019;53(2):144-150. Epub ahead of print September 2018.
  12. Petite SE. Noninsulin medication therapy for hospitalized patients with diabetes mellitus. Am J Health Syst Pharm 2018;75(18):1361-1368.
  13. Petite SE. Characterization of pharmacy resident interventions on an academic inpatient internal medicine rotation. J Pharm Pract 2019;32(6):625-628. Epub ahead of print May 2018.
  14. Petite SE, Murphy JA. Evaluation of bronchodilator use during chronic obstructive pulmonary disease exacerbation inpatient admissions. Hosp Pharm 2018;20(6):519-523. Epub ahead of print April 2018.
  15. Petite SE. Characterization of chronic obstructive pulmonary disease prescribing patterns in the United States. Pulm Pharmacol Ther 2018;49:119-122. Epub ahead of print February 2018.
  16. Petite SE, Nguyen K. Evaluation of antimicrobial therapy duration for hospital-acquired pneumonia treatment. Infect Dis Clin Pract 2018;26:87-90. Epub ahead of print September 2017.
  17. Petite SE. Role of long-acting muscarinic antagonist/long-acting beta2-agonist therapy in chronic obstructive pulmonary disease. Ann Pharmacother 2017;51:696-705. Epub ahead of print April 2017.
  18. Petite SE, Bauer S, Bollinger JE, Ahrens C, Harinstein L. Antimicrobial monotherapy versus combination therapy for the treatment of complicated intra-abdominal infections. Pharmacotherapy 2016; 36:1138-1144. Epub ahead of print October 2016.
  19. Petite SE, Bollinger JE, Eghtesad B. Antithymocyte globulin induction therapy in liver transplant: old drug, new uses. Ann Pharmacother 2016;50:592-598. Epub ahead of print May 2016.
  20. Petite SE, Bishop BM, Mauro VF. Role of the funny current inhibitor ivabradine in cardiac pharmacotherapy: A systematic review. Am J Ther 2018;25:e247-e266. Epub ahead of print February 2016.

Peer Reviewed Abstracts

  1. Eberhard C, Petite SE. Evaluation of basal insulin dose reductions in hospitalized patients while unable to eat. JACCP 2020;3:1527.
  2. Rader W, Petite S, Murphy J. Assessment of the use of procalcitonin in hospitalized non-critically ill patients with chronic obstructive pulmonary disease exacerbations. JACCP 2020;3:1638.
  3. Alauddin T, Petite SE. Evaluation of the safety and efficacy of metformin use in hospitalized, non-critically ill patients. JACCP 2020;3(1):146.

Letters to the Editor

  1. Petite SE. Single-inhaler triple therapy versus dual therapy in COPD. N Engl J Med 2018;379:591-592.

Click here to view more publications.

Last Updated: 7/15/24